PILA PHARMA
1.18 SEK
+0.85 %
Less than 1K followers
PILA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for PILA PHARMA
EV/S
Median 2021-2025
P/B
Median 2021-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | - | - | 5.92 | 2.76 | 1.43 | 3.34 | 2.06 |
| Shares | 18.5 | 18.5 | 18.5 | 20.6 | 26.7 | 30.4 | 42.1 |
| Market cap | - | - | 109.5 | 57.0 | 38.1 | 101.7 | 86.7 |
| Enterprise value | - | - | 81.3 | 49.7 | - | - | 70.8 |
| EV/S | - | - | 113.0 | 26.5 | - | - | 62.6 |
| EV/EBITDA | - | - | neg. | neg. | - | - | neg. |
| EV/EBIT | - | - | neg. | neg. | - | - | neg. |
| P/E | - | - | neg. | neg. | neg. | neg. | neg. |
| P/B | - | - | 3.61 | 5.98 | 5.72 | 19.34 | 5.87 |
| P/S | - | - | 152.3 | 30.3 | 26.1 | 130.4 | 76.7 |
| Dividend yield | - | - | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.9 % | 63.7 % | 95.2 % | 87.5 % | 78.7 % | 84.6 % | 91.1 % |
| Gearing ratio | - | 14.6 % | - | - | - | - | - |